EU supports expansion of Tunisian pharmaceutical company TERIAK

May 13, 2019
Share on

The European Bank for Reconstruction and Development (EBRD) and the EU are joining forces to support the growth of a dynamic privately-owned Tunisian pharmaceutical firm, Teriak. The company will benefit from financial and technical support to strengthen its competitiveness. It will receive an EBRD loan of 11.7 million Tunisian dinars (equivalent to €3.4 million), a technical assistance package and a €0.5 million grant from the EU through a programme specifically designed to boost value chains and competitiveness of small and medium-sized enterprises in the region.

The EBRD places a strong priority on providing finance for private sector firms in Tunisia, where it has invested a total of over €850 million since the start of its operations in the country in 2012 and provided technical assistance to nearly 800 SMEs, two thirds of which are in the regions.

The Bank’s investments aim to support Tunisia’s competitiveness by opening markets and strengthening governance, promote economic inclusion for women, young people and those living in remote areas, strengthen the financial sector’s resilience, and support Tunisia’s green economy transition.

Read more

Press release


Countries covered:

  • Tunisia